Items stated in the management plan
Annual updateAs the tender offer by Omron Healthcare Co., Ltd. for the Company's shares and other securities was completed, the Company is expected to be delisted after completing the procedures for becoming a wholly owned subsidiary. Accordingly, no earnings forecast for the fiscal year ending March 2027 is provided.
| Item | Details |
|---|---|
| Plan name | Business Plan and Growth Potential |
| Progress against the plan | Annual update |
| Payout ratio / DOE policy | The basic policy is to pay a year-end dividend once a year and provide stable and continuous returns to shareholders. The applicable period is thereafter. Numerical targets for the payout ratio and DOE are not disclosed. |
| Non-financial targets | Indicator name Target headcount through automation / Target value Approximately 4 people / Timing Not disclosed |
| Plan assumptions | The blood pressure monitor market is forecast to grow from US$4.28 billion in 2025 to US$7.99 billion in 2032, at a CAGR of 9.3%., The global automotive airbag market is forecast to grow from US$27.9 billion in 2025 to US$48.2 billion in 2030, at a CAGR of 11.51%., The global automotive seat market is forecast to grow from US$73.96 billion in 2025 to US$87.88 billion in 2032, at a CAGR of 3.51%., Consolidated net sales grew at a CAGR of 10.01% from the fiscal year ended March 2017 to the fiscal year ended March 2026., Growth in the hypertensive population, rising demand for rehabilitation associated with population aging, labor shortages in the healthcare industry, growing attention to low-cost labor in Vietnam, and rising labor costs due to labor shortages and wage increases |
| Key initiatives | Strengthen initiatives related to blood pressure monitor cuffs, including promoting process automation and reviewing the supply chain, Strengthen the rehabilitation robot business, including efforts to introduce new products, Enter new business areas, including wearable devices, Ensure stable operation of the new plant in Vietnam and strengthen MIC's development capabilities, Strengthen overseas sales of automated sewing machines, Expand transactions in the airbag and car seat businesses, Enter new business areas, including services to improve the efficiency of cutting processes and production management systems, etc., Development of airbags for drones |
| Reason for revision or withdrawal | As the tender offer by Omron Healthcare Co., Ltd. for the Company's shares and other securities was completed, the Company is expected to be delisted after completing the procedures for becoming a wholly owned subsidiary. Accordingly, no earnings forecast for the fiscal year ending March 2027 is provided. |
| Size of the Target Market | Market Blood pressure monitor market / Scale US$4.28 billion in 2025 and US$7.99 billion in 2032 / Growth rate CAGR9.3% / Source Coherent Market Insights, Market Global automotive airbag market / Scale US$27.9 billion in 2025 and US$48.2 billion in 2030 / Growth rate CAGR11.51% / Source Report Ocean, Market Global automotive seat market / Scale US$73.96 billion in 2025 and US$87.88 billion in 2032 / Growth rate CAGR3.51% / Source Mordor Intelligence, Market Rehabilitation-related market / Scale ¥182.3 billion in 2020 and a forecast ¥266.3 billion in 2030 / Growth rate Not disclosed / Source According to Fuji Keizai |
| Risks identified | Dependence on transactions with specific customers, Overseas business activities, Quality control, Research and development, Recruitment and development of human resources, For other risks, refer to the Annual Securities Report, Part II: Business Overview, 3. Business and Other Risks |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As the tender offer by Omron Healthcare Co., Ltd. was completed, the Company is expected to be delisted after completing the procedures for becoming a wholly owned subsidiary. Accordingly, no earnings forecast for the fiscal year ending March 2027 is provided.